This drug – a mixture of trimethoprim and the sulphonamide sulphamethoxazole – is now recommended only in the prophylaxis or treatment of pneumocystis PNEUMONIA, and in acute exacerbations of chronic BRONCHITIS, urinary tract infections and otitis media (see EAR, DISEASES OF), where indicated.